MK
Mahesh Kumar Agarwal
About Mahesh Kumar Agarwal
Data last updated:
Mahesh Kumar Agarwal is a Director at Sri Navdurga Billets Private Limited (since 2007), Director at Sri Swastik Siddhatva Private Limited (since 1993) and Director at Cure Thalassemia (since 2011). The companies operate in Metals and Minerals, Manufacturing and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹732 Cr; the largest is Sri Navdurga Billets Private Limited at ₹629 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sri Navdurga Billets Private Limited U27109TG2007PTC055497 | Director | 13 Sep 2007 | 2007 | ₹629 Cr (FY 2025) | Active |
 Sri Swastik Siddhatva Private Limited U17110TG1990PTC011282 | Director | 28 May 1993 | 1990 | ₹103 Cr (FY 2025) | Active |
| Cure Thalassemia U85100TG2011NPL075631 | Director | 21 Jul 2011 | 2011 | Active |
Board colleagues of Mahesh Kumar Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rishikant Agarwal | 02218146 | Sri Navdurga Billets Private Limited , Sri Swastik Siddhatva Private Limited | Director |
| Sachin Kumar Agarwal | 01805570 | Sri Navdurga Billets Private Limited | Director |
| Shashi Kant Agarwal | 01529100 | Sri Navdurga Billets Private Limited | Managing Director |
| Kamal Kant Agarwal | 01732477 | Sri Swastik Siddhatva Private Limited | Managing Director |
| Chandrakant Agrawal | 01483264 | Cure Thalassemia | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahesh Kumar Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahesh Kumar Agarwal
Mahesh Kumar Agarwal currently holds 3 directorships: Sri Navdurga Billets Private Limited (Director, since 13 Sep 2007, revenue ₹629 Cr (FY 2025)); Sri Swastik Siddhatva Private Limited (Director, since 28 May 1993, revenue ₹103 Cr (FY 2025)); Cure Thalassemia (Director, since 21 Jul 2011).
Mahesh Kumar Agarwal was first appointed on 28 May 1993 as Director at Sri Swastik Siddhatva Private Limited. The most recent appointment on record is 21 Jul 2011 at Cure Thalassemia.
The 2 current companies of Mahesh Kumar Agarwal that report revenue have a combined latest revenue of ₹732 Cr: Sri Navdurga Billets Private Limited ₹629 Cr (FY 2025); Sri Swastik Siddhatva Private Limited ₹103 Cr (FY 2025).
The current boards of Mahesh Kumar Agarwal's companies include Rishikant Agarwal (Sri Navdurga Billets Private Limited), Sachin Kumar Agarwal (Sri Navdurga Billets Private Limited), Shashi Kant Agarwal (Sri Navdurga Billets Private Limited), Kamal Kant Agarwal (Sri Swastik Siddhatva Private Limited), Chandrakant Agrawal (Cure Thalassemia).